Mylan To Pay $65M To Bury Medicaid Inflation Claims
Mylan Inc. will pay $65 million to settle allegations brought by the state of Texas that the drugmaker inflated Medicaid reimbursements by concealing discounts it provided to pharmacies in violation of...To view the full article, register now.
Already a subscriber? Click here to view full article